Upgrade to SI Premium - Free Trial

Bernstein SocGen Reiterates Market Perform Rating on Moderna (MRNA)

September 25, 2026 8:09 AM
Bernstein SocGen Group analyst Courtney Breen reiterated a Market Perform rating and $45.00 price target on Moderna (NASDAQ: MRNA).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments